<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1370">
  <stage>Registered</stage>
  <submitdate>15/11/2006</submitdate>
  <approvaldate>15/11/2006</approvaldate>
  <nctid>NCT00400257</nctid>
  <trial_identification>
    <studytitle>Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)</studytitle>
    <scientifictitle>SCREEN-HF (Screening Evaluation of the Evolution of New Heart Failure)</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CP-04/06</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Heart Failure</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behaviour - Early detection of heart failure

1 - People at high risk of heart failure.


Behaviour: Early detection of heart failure
Early detection of heart failure

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To assess the effectiveness of BNP in determining Heart Failure in people not previously diagnosed with the condition.</outcome>
      <timepoint>at visit 2</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Age =60 years

          2. Have been insured with HBA for 12 months or longer (Protocol amended to remove this
             criteria and allow enrollment of the general public)

          3. Subjects at high-risk of subsequent development of heart failure; comprising at least
             one of:

               -  Prior myocardial infarction (MI) without known left ventricular (LV) dysfunction

               -  Current active ischemic heart disease

               -  Prior Cerebrovascular Accident (CVA)

               -  Known valvular heart disease without known LV dysfunction

               -  Atrial fibrillation

               -  Ventricular arrhythmia resulting in syncope or pre-syncope (protocol amended to
                  remove this entry criteria)

               -  Treated hypertension, of at least 2 years duration

               -  Treated Diabetes mellitus, of at least 2 years duration

               -  Estimated Glomerular Filtration Rate (eGFR) &lt;50ml/min</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Known systolic or diastolic heart failure

          2. Symptoms suggestive of current heart failure. (protocol amended to remove this
             criteria)

          3. LV systolic or diastolic dysfunction on echocardiography or other objective imaging
             modality.

          4. Medications for treatment of heart failure such as ACE inhibitors, angiotensin
             receptor blockers (ARBs), beta-blockers or aldosterone antagonists. Use of such
             medications for approved indications such as hypertension, post-MI management (without
             known LV dysfunction) or for diabetic nephropathy is permitted. (protocol amended to
             remove this criteria)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>3500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2015</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Ingrid Hopper</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>HBA</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The investigators are hoping to identify early heart failure in patients who do not have
      symptoms as yet and at the same time assess the usefulness of Brain natriuretic peptide (BNP)
      in doing this.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00400257</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Henry Krum, Professor</name>
      <address>Monash University / Alfred Hospital</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>